Literature DB >> 3598467

Correlation of T cell receptor V beta gene family with MHC restriction.

P A Morel, A M Livingstone, C G Fathman.   

Abstract

We have studied a panel of DBA/2 T cell clones specific for sperm whale myoglobin (SpW Mb) for TCR (T cell receptor) beta chain gene expression by FACS analysis using the monoclonal antibodies F23.1 and KJ16 specific for the V beta 8 family of the TCR beta chain genes. Within any given specificity group, all the clones tested came from different mice. 10 of 11 I-Ed-restricted SpW Mb-specific T cell clones were F23.1+; 8 of these were also KJ16+. Only one of the three I-Ad-restricted clones tested was F23.1+; this clone was KJ16 negative. This study has demonstrated that I-Ed-restricted T cell clones from DBA/2 mice express members of the TCR V beta 8 family irrespective of the epitopes of SpW Mb recognized. These data suggest an apparent correlation between TCR V beta expression and MHC restriction.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3598467      PMCID: PMC2189600          DOI: 10.1084/jem.166.2.583

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  T cell clones to two major T cell epitopes of myoglobin: effect of I-A/I-E restriction on epitope dominance.

Authors:  I Berkower; H Kawamura; L A Matis; J A Berzofsky
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

2.  Correlations between T-cell specificity and the structure of the antigen receptor.

Authors:  P J Fink; L A Matis; D L McElligott; M Bookman; S M Hedrick
Journal:  Nature       Date:  1986 May 15-21       Impact factor: 49.962

3.  Antigenic competition at the level of peptide-Ia binding.

Authors:  B P Babbitt; G Matsueda; E Haber; E R Unanue; P M Allen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

Review 4.  Genes of the T-cell antigen receptor in normal and malignant T cells.

Authors:  B Toyonaga; T W Mak
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

5.  Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens.

Authors:  V T Oi; P P Jones; J W Goding; L A Herzenberg; L A Herzenberg
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

6.  Interferon-gamma-induced IA expression in WEHI-3 cells is enhanced by the presence of 1,25-dihydroxyvitamin D3.

Authors:  P A Morel; S C Manolagas; D M Provvedini; D R Wegmann; J M Chiller
Journal:  J Immunol       Date:  1986-03-15       Impact factor: 5.422

7.  Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor.

Authors:  U D Staerz; H G Rammensee; J D Benedetto; M J Bevan
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

8.  V beta gene polymorphism and a major polyclonal T cell receptor idiotype.

Authors:  G K Sim; A A Augustin
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

9.  The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype.

Authors:  K Haskins; C Hannum; J White; N Roehm; R Kubo; J Kappler; P Marrack
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

10.  Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.

Authors:  J W Kappler; B Skidmore; J White; P Marrack
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  28 in total

1.  CD3+ CD57+ lymphocytes are not likely to be involved in antigen-specific rejection processes in long-term allograft recipients.

Authors:  B Reipert; C Scheuch; A Lukowsky; P Reinke; E Fietze; W D Döcke; G Staffa; S Czerlinksi; R Hetzer; H D Volk
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

Review 2.  Multiple sclerosis and its animal models: the role of the major histocompatibility complex and the T cell receptor repertoire.

Authors:  L Steinman
Journal:  Springer Semin Immunopathol       Date:  1992

3.  The presumptive CDR3 regions of both T cell receptor alpha and beta chains determine T cell specificity for myoglobin peptides.

Authors:  J S Danska; A M Livingstone; V Paragas; T Ishihara; C G Fathman
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

4.  T-cell receptors from virus-specific cytotoxic T lymphocytes recognizing a single immunodominant nine-amino-acid viral epitope show marked diversity.

Authors:  M S Horwitz; Y Yanagi; M B Oldstone
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

5.  Clonal diversity of myelin basic protein-specific T lymphocytes.

Authors:  S K Huang; S Sriram
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

6.  The minimal polymorphism of class II E alpha chains is not due to the functional neutrality of mutations.

Authors:  Z T Chu; C Carswell-Crumpton; B C Cole; P P Jones
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

7.  Dominant V beta 8 gene usage in response to TNP: failure to use other V beta chains following removal of V beta 8+ T cells by monoclonal antibody in vivo.

Authors:  F Dieli; G L Asherson; G Sireci; G Tantillo; C del Carpio; A Salerno
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

8.  Analysis of human T-cell receptor V beta gene usage following immunization to tetanus toxoid in vivo.

Authors:  M L Hibberd; F S Wong; L B Nicholson; A G Demaine
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

9.  Generation of DC from mouse spleen cell cultures in response to GM-CSF: immunophenotypic and functional analyses.

Authors:  L Lu; M Hsieh; T B Oriss; P A Morel; T E Starzl; A S Rao; A W Thomson
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

10.  Selective activation and accumulation of oligoclonal V beta-specific T cells in active pulmonary sarcoidosis.

Authors:  J D Forman; J T Klein; R F Silver; M C Liu; B M Greenlee; D R Moller
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.